13. Multiple sclerosis/Neuromyelitis optica Disease details / Clinical trials / Drug dev / DR info


Clinical trials : 3,685 /  Drugs : 1,932 - (DrugBank : 355) / Drug target genes : 263 - Drug target pathways : 237

Multiple sclerosis/Neuromyelitis optica and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)